Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 35, 2018 - Issue 10
975
Views
33
CrossRef citations to date
0
Altmetric
Reviews

The neurobiology of adaptation to seasons: Relevance and correlations in bipolar disorders

, , , , &
Pages 1335-1353 | Received 23 Mar 2018, Accepted 07 Jun 2018, Published online: 25 Jun 2018

References

  • Abreu T, Braganca M. 2015. The bipolarity of light and dark: A review on bipolar disorder and circadian cycles. J Affect Disord. 185:219–29.
  • Ahn YM, Chang J, Joo YH, Kim SC, Lee KY, Kim YS. 2008. Chronotype distribution in bipolar I disorder and schizophrenia in a Korean sample. Bipolar Disord. 10:271–75.
  • Amir S, Robinson B, Ratovitski T, Rea MA, Stewart J, Simantov R. 1998. A role for serotonin in the circadian system revealed by the distribution of serotonin transporter and light-induced Fos immunoreactivity in the suprachiasmatic nucleus and intergeniculate leaflet. Neuroscience. 84:1059–73.
  • Anderson G. 2018. Linking the biological underpinnings of depression: Role of mitochondria interactions with melatonin, inflammation, sirtuins, tryptophan catabolites, DNA repair and oxidative and nitrosative stress, with consequences for classification and cognition. Prog Neuropsychopharmacol Biol Psych. 80:255–66.
  • Anderson G, Beischlag TV, Vinciguerra M, Mazzoccoli G. 2013. The circadian clock circuitry and the AHR signaling pathway in physiology and pathology. Biochem Pharmacol. 85:1405–16.
  • Anderson G, Jacob A, Bellivier F, Geoffroy PA. 2016. Bipolar disorder: The role of the kynurenine and melatonergic pathways. Curr Pharm Des. 22:987–1012.
  • Anderson G, Maes M. 2014. Local melatonin regulates inflammation resolution: A common factor in neurodegenerative, psychiatric and systemic inflammatory disorders. CNS Neurol Disord Drug Targets. 13:817–27.
  • Anderson G, Maes M. 2017. Interactions of tryptophan and its catabolites with melatonin and the alpha 7 nicotinic receptor in central nervous system and psychiatric disorders: Role of the aryl hydrocarbon receptor and direct mitochondria regulation. Int J Tryptophan Res. 10:1178646917691738.
  • Anderson RJ, Gott BM, Sayuk GS, Freedland KE, Lustman PJ. 2010. Antidepressant pharmacotherapy in adults with type 2 diabetes: Rates and predictors of initial response. Diabetes Care. 33:485–89.
  • Aton SJ, Colwell CS, Harmar AJ, Waschek J, Herzog ED. 2005. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat Neurosci. 8:476–83.
  • Benedetti F, Dallaspezia S, Colombo C, Pirovano A, Marino E, Smeraldi E. 2008. A length polymorphism in the circadian clock gene Per3 influences age at onset of bipolar disorder. Neurosci Lett. 445:184–87.
  • Berk M, Post R, Ratheesh A, Gliddon E, Singh A, Vieta E, Carvalho AF, Ashton MM, Berk L, Cotton SM, et al. 2017. Staging in bipolar disorder: From theoretical framework to clinical utility. World Psych. 16:236–44.
  • Boerman R, Cohen D, Schulte PF, Nugter A. 2016. Prevalence of vitamin D deficiency in adult outpatients with bipolar disorder or schizophrenia. J Clin Psychopharmacol. 36:588–92.
  • Boudebesse C, Lajnef M, Geoffroy PA, Bellivier F, Nieto I, Gard S, Olie E, Azorin JM, Kahn JP, Bougerol T, et al,, . 2013. Chronotypes of bipolar patients in remission: Validation of the French version of the circadian type inventory in the FACE-BD sample. Chronobiol Int. 30:1042–49. doi:10.3109/07420528.2013.798330.
  • Cannon DM, Ichise M, Fromm SJ, Nugent AC, Rollis D, Gandhi SK, Klaver JM, Charney DS, Manji HK, Drevets WC. 2006. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biol Psych. 60:207–17.
  • Carlsson A, Svennerholm L, Winblad B. 1980. Seasonal and circadian monoamine variations in human brains examined post mortem. Acta Psychiatr Scand Suppl. 280:75–85.
  • Cermakian N, Boivin DB. 2003. A molecular perspective of human circadian rhythm disorders. Brain Res Rev. 42:204–20.
  • Clark A, Mach N. 2016. Role of vitamin D in the hygiene hypothesis: The interplay between vitamin D, vitamin D receptors, gut microbiota, and immune response. Front Immunol. 7:627.
  • Coomans CP, Ramkisoensing A, Meijer JH. 2015. The suprachiasmatic nuclei as a seasonal clock. Front Neuroendocrinol. 37:29–42.
  • De Melo LGP, Nunes SOV, Anderson G, Vargas HO, Barbosa DS, Galecki P, Carvalho AF, Maes M. 2017. Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders. Prog Neuropsychopharmacol Biol Psych. 78:34–50.
  • Dulcis D, Jamshidi P, Leutgeb S, Spitzer NC. 2013. Neurotransmitter switching in the adult brain regulates behavior. Science. 340:449–53.
  • Etain B, Dumaine A, Bellivier F, Pagan C, Francelle L, Goubran-Botros H, Moreno S, Deshommes J, Moustafa K, Le Dudal K, et al. 2012. Genetic and functional abnormalities of the melatonin biosynthesis pathway in patients with bipolar disorder. Hum Mol Genet. 21:4030–37.
  • Etain B, Milhiet V, Bellivier F, Leboyer M. 2011. Genetics of circadian rhythms and mood spectrum disorders. Eur Neuropsychopharmacol. 21 Suppl 4:S676–682.
  • Faedda GL, Tondo L, Teicher MH, Baldessarini RJ, Gelbard HA, Floris GF. 1993. Seasonal mood disorders. Patterns of seasonal recurrence in mania and depression. Arch Gen Psych. 50:17–23.
  • Farajnia S, Van Westering TL, Meijer JH, Michel S. 2014. Seasonal induction of GABAergic excitation in the central mammalian clock. Proc Natl Acad Sci USA. 111:9627–32.
  • Flowers SA, Evans SJ, Ward KM, McInnis MG, Ellingrod VL. 2017. Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort. Pharmacotherapy. 37:261–67.
  • Geoffroy PA, Bellivier F, Scott J, Boudebesse C, Lajnef M, Gard S, Kahn JP, Azorin JM, Henry C, Leboyer M, et al. 2013. Bipolar disorder with seasonal pattern: Clinical characteristics and gender influences. Chronobiol Int. 30:1101–07.
  • Geoffroy PA, Bellivier F, Scott J, Etain B. 2014a. Seasonality and bipolar disorder: A systematic review, from admission rates to seasonality of symptoms. J Affect Disord. 168:210–23.
  • Geoffroy PA, Boudebesse C, Bellivier F, Lajnef M, Henry CLeboyer M, Scott J, Etain B.J Affect Disord. 2014 Apr;158:1-7. doi:10.1016/j.jad.2014.01.012. Epub 2014 Jan 30.
  • Geoffroy PA, Boudebesse C, Henrion A, Jamain S, Henry C, Leboyer M, Bellivier F, Etain B. 2014b. An ASMT variant associated with bipolar disorder influences sleep and circadian rhythms: A pilot study. Genes Brain Behav. 13:299–304.
  • Geoffroy PA, Etain B, Franchi JA, Bellivier F, Ritter P. 2015a. Melatonin and melatonin agonists as adjunctive treatments in bipolar disorders. Curr Pharm Des. 21:3352–58.
  • Geoffroy PA, Godin O, Mahee D, Henry C, Aubin V, Azorin JM, Bougerol T, Courtet P, Gard S, Kahn JP, et al. 2017. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort. Chronobiol Int. 34:845–54.
  • Geoffroy PA, Lajnef M, Bellivier F, Jamain S, Gard S, Kahn JP, Henry C, Leboyer M, Etain B. 2015b. Genetic association study of circadian genes with seasonal pattern in bipolar disorders. Sci Rep. 5:10232.
  • Geoffroy PA, Scott J, Boudebesse C, Lajnef M, Henry C, Leboyer M, Bellivier F, Etain B. 2015c. Reply: Sleep in patients with remitted bipolar disorders: Analyses stratified on actigraphy devices, age and gender. Acta Psychiatr Scand. 131:400.
  • Geoffroy PA, Scott J, Boudebesse C, Lajnef M, Henry C, Leboyer M, Bellivier F, Etain B. 2015d. Sleep in patients with remitted bipolar disorders: A meta-analysis of actigraphy studies. Acta Psychiatr Scand. 131:89–99.
  • Godson C, Reppert SM. 1997. The Mel1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology. 138:397–404.
  • Gonzalez R. 2014. The relationship between bipolar disorder and biological rhythms. J Clin Psych. 75:e323–331.
  • Guissoni Campos LM, Buchaim RL, da Silva NC, Spilla CSG, Hataka A, Pinato L. 2017. Suprachiasmatic nucleus and subordinate brain oscillators: Clock gene desynchronization by neuroinflammation. Neuroimmunomodulation. 24:231–41.
  • Hannibal J, Fahrenkrug J. 2006. Neuronal input pathways to the brain’s biological clock and their functional significance. Adv Anat Embryol Cell Biol. 182:1–71.
  • Harvey AG. 2008. Sleep and circadian rhythms in bipolar disorder: Seeking synchrony, harmony, and regulation. Am J Psych. 165:820–29.
  • Harvey AG, Mullin BC, Hinshaw SP. 2006. Sleep and circadian rhythms in children and adolescents with bipolar disorder. Dev Psychopathol. 18:1147–68.
  • Hazlerigg DG, Wagner GC. 2006. Seasonal photoperiodism in vertebrates: From coincidence to amplitude. Trends Endocrinol Metab. 17:83–91.
  • Ichimiya T, Suhara T, Sudo Y, Okubo Y, Nakayama K, Nankai M, Inoue M, Yasuno F, Takano A, Maeda J, et al. 2002. Serotonin transporter binding in patients with mood disorders: A PET study with [11C](+)McN5652. Biol Psych. 51:715–22.
  • Illnerova H, Vanecek J. 1980. Pineal rhythm in N-acetyltransferase activity in rats under different artificial photoperiods and in natural daylight in the course of a year. Neuroendocrinology. 31:321–26.
  • Illnerova H, Vanecek J. 1985. Entrainment of the circadian rhythm in rat pineal N-acetyltransferase activity under extremely long and short photoperiods. J Pineal Res. 2:67–78.
  • Jaeger C, Tischkau SA. 2016. Role of aryl hydrocarbon receptor in circadian clock disruption and metabolic dysfunction. Environ Health Insights. 10:133–41.
  • Jeong JK, Park SY. 2015. Melatonin regulates the autophagic flux via activation of alpha-7 nicotinic acetylcholine receptors. J Pineal Res. 59:24–37.
  • Jin CJ, Engstler AJ, Sellmann C, Ziegenhardt D, Landmann M, Kanuri G, Lounis H, Schroder M, Vetter W, Bergheim I. 2016. Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: Role of melatonin and lipid peroxidation. Br J Nutr. 2016 Nov 23: 1–12.
  • Johnston JD, Ebling FJ, Hazlerigg DG. 2005. Photoperiod regulates multiple gene expression in the suprachiasmatic nuclei and pars tuberalis of the Siberian hamster (Phodopus sungorus). Eur J Neurosci. 21:2967–74.
  • Kaczmarek JL, Thompson SV, Holscher HD. 2017. Complex interactions of circadian rhythms, eating behaviors, and the gastrointestinal microbiota and their potential impact on health. Nutr Rev. 75:673–82.
  • Kasahara K, Tanoue T, Yamashita T, Yodoi K, Matsumoto T, Emoto T, Mizoguchi T, Hayashi T, Kitano N, Sasaki N, et al. 2017. Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis. J Lipid Res. 58:519–28.
  • Kennedy SH, Kutcher SP, Ralevski E, Brown GM. 1996. Nocturnal melatonin and 24-hour 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder. Psych Res. 63:219–22.
  • Kim JS, Ha TH, Chang JS, Park YS, Huh I, Kim J, Hong KS, Park T, Ha K. 2015. Seasonality and its distinct clinical correlates in bipolar II disorder. Psych Res. 225:540–44.
  • Kim Y, Santos R, Gage FH, Marchetto MC. 2017. Molecular mechanisms of bipolar disorder: Progress made and future challenges. Front Cell Neurosci. 11:30.
  • Klein DCBerg GR. 1970. Pineal gland: stimulation of melatonin production by norepinephrine involves cyclic amp-mediated stimulation of n-acetyltransferase. Advances in Biochemical Psychopharmacology. 3:241–263.
  • Klein DC, Weller J. 1970. Input and output signals in a model neural system: The regulation of melatonin production in the pineal gland. In Vitro. 6:197–204.
  • Kumar A, Narayanaswamy JC, Venkatasubramanian G, Raguram R, Grover S, Aswath M. 2017. Prevalence of metabolic syndrome and its clinical correlates among patients with bipolar disorder. Asian J Psychiatr. 26:109–14.
  • Kundu R, Theodoraki A, Haas CT, Zhang Y, Chain B, Kriston-Vizi J, Noursadeghi M, Khoo B. 2017. Cell-type-specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes. Immunology. 150:55–63.
  • Lavoie MP, Lam RW, Bouchard G, Sasseville A, Charron MC, Gagne AM, Tremblay P, Filteau MJ, Hebert M. 2009. Evidence of a biological effect of light therapy on the retina of patients with seasonal affective disorder. Biol Psych. 66:253–58.
  • Lee HJ, Woo HG, Greenwood TA, Kripke DF, Kelsoe JR. 2013. A genome-wide association study of seasonal pattern mania identifies NF1A as a possible susceptibility gene for bipolar disorder. J Affect Disord. 145:200–07.
  • Levitan RD. 2007. The chronobiology and neurobiology of winter seasonal affective disorder. Dialogues Clin Neurosci. 9:315–24.
  • Lewy AJ, Sack RL, Miller LS, Hoban TM. 1987. Antidepressant and circadian phase-shifting effects of light. Science. 235:352–54.
  • Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM. 2009. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet. 373:234–39.
  • Lima MM, Andersen ML, Reksidler AB, Silva A, Zager A, Zanata SM, Vital MA, Tufik S. 2008. Blockage of dopaminergic D(2) receptors produces decrease of REM but not of slow wave sleep in rats after REM sleep deprivation. Behav Brain Res. 188:406–11.
  • Lucassen EA, van Diepen HC, Houben T, Michel S, Colwell CS, Meijer JH. 2012. Role of vasoactive intestinal peptide in seasonal encoding by the suprachiasmatic nucleus clock. Eur J Neurosci. 35:1466–74.
  • Magnusson A. 2000. An overview of epidemiological studies on seasonal affective disorder. Acta Psychiatr Scand. 101:176–84.
  • Malek ZS, Sage D, Pevet P, Raison S. 2007. Daily rhythm of tryptophan hydroxylase-2 messenger ribonucleic acid within raphe neurons is induced by corticoid daily surge and modulated by enhanced locomotor activity. Endocrinology. 148:5165–72.
  • Mansour HA, Wood J, Chowdari KV, Dayal M, Thase ME, Kupfer DJ, Monk TH, Devlin B, Nimgaonkar VL. 2005. Circadian phase variation in bipolar I disorder. Chronobiol Int. 22:571–84.
  • Markus RP, Cecon E, Pires-Lapa MA. 2013. Immune-pineal axis: Nuclear factor kappaB (NF-kB) mediates the shift in the melatonin source from pinealocytes to immune competent cells. Int J Mol Sci. 14:10979–97.
  • Marti-Soler H, Gubelmann C, Aeschbacher S, Alves L, Bobak M, Bongard V, Clays E, de Gaetano G, Di Castelnuovo A, Elosua R, et al. 2014. Seasonality of cardiovascular risk factors: An analysis including over 230 000 participants in 15 countries. Heart. 100:1517–23.
  • Maywood ES, Chesham JE, O’Brien JA, Hastings MH. 2011. A diversity of paracrine signals sustains molecular circadian cycling in suprachiasmatic nucleus circuits. Proc Natl Acad Sci USA. 108:14306–11.
  • McClung CA. 2011. Circadian rhythms and mood regulation: Insights from pre-clinical models. Eur Neuropsychopharmacol. 21 Suppl 4:S683–693.
  • Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC. 2007. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psych. 64:543–52.
  • Milhiet V, Etain B, Boudebesse C, Bellivier F. 2011. Circadian biomarkers, circadian genes and bipolar disorders. J Physiol Paris. 105:183–89.
  • Molendijk ML, Bus BA, Spinhoven P, Kaimatzoglou A, Oude Voshaar RC, Penninx BW, van IMH, Elzinga BM. 2012a. A systematic review and meta-analysis on the association between BDNF val(66)met and hippocampal volume – a genuine effect or a winners curse? Am J Med Genet Part B. 159B:731–40.
  • Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Prickaerts J, Oude Voshaar RC, Elzinga BM. 2012b. Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety. World J Biol Psych. 13:535–43.
  • Moreira J, Geoffroy PA. 2016. Lithium and bipolar disorder: Impacts from molecular to behavioural circadian rhythms. Chronobiol Int. 33:351–73.
  • Morris G, Walder K, McGee SL, Dean OM, Tye SJ, Maes M, Berk M. 2017. A model of the mitochondrial basis of bipolar disorder. Neurosci Biobehav Rev. 74:1–20.
  • Mukherjee D, Krishnamurthy VB, Millett CE, Reider A, Can A, Groer M, Fuchs D, Postolache TT, Saunders EFH. 2018. Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder. Bipolar Disord. 20:27–34.
  • Murray G, Harvey A. 2010. Circadian rhythms and sleep in bipolar disorder. Bipolar Disord. 12:459–72.
  • Nathan PJ, Burrows GD, Norman TR. 1999. Melatonin sensitivity to dim white light in affective disorders. Neuropsychopharmacology. 21:408–13.
  • Neumeister A, Willeit M, Praschak-Rieder N, Asenbaum S, Stastny J, Hilger E, Pirker W, Konstantinidis A, Kasper S. 2001. Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychol Med. 31:1467–73.
  • Nurnberger JI Jr., Adkins S, Lahiri DK, Mayeda A, Hu K, Lewy A, Miller A, Bowman ES, Miller MJ, Rau L, et al. 2000. Melatonin suppression by light in euthymic bipolar and unipolar patients. Arch Gen Psych. 57:572–79.
  • Ogden RT, Ojha A, Erlandsson K, Oquendo MA, Mann JJ, Parsey RV. 2007. In vivo quantification of serotonin transporters using [(11)C]DASB and positron emission tomography in humans: Modeling considerations. J Cereb Blood Flow Metab. 27:205–17.
  • Oquendo MA, Galfalvy H, Sullivan GM, Miller JM, Milak MM, Sublette ME, Cisneros-Trujillo S, Burke AK, Parsey RV, Mann JJ. 2016. Positron emission tomographic imaging of the serotonergic system and prediction of risk and lethality of future suicidal behavior. JAMA Psych. 73:1048–55.
  • Oren DA. 1991. Retinal melatonin and dopamine in seasonal affective disorder. J Neural Transm General Sect. 83:85–95.
  • Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS, Hogenesch JB. 2002. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell. 109:307–20.
  • Pandi-Perumal SR, Srinivasan V, Maestroni GJ, Cardinali DP, Poeggeler B, Hardeland R. 2006. Melatonin: Nature’s most versatile biological signal? FEBS J. 273:2813–38.
  • Prosser RA, Dean RR, Edgar DM, Heller HC, Miller JD. 1993. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists. J Biol Rhythms. 8:1–16.
  • Ritter PS, Marx C, Lewtschenko N, Pfeiffer S, Leopold K, Bauer M, Pfennig A. 2012. The characteristics of sleep in patients with manifest bipolar disorder, subjects at high risk of developing the disease and healthy controls. J Neural Transm. 119:1173–84.
  • Robillard R, Naismith SL, Rogers NL, Ip TK, Hermens DF, Scott EM, Hickie IB. 2013. Delayed sleep phase in young people with unipolar or bipolar affective disorders. J Affect Disord. 145:260–63.
  • Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, Newsome DA, Wehr TA. 1984. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psych. 41:72–80.
  • Saper CB, Scammell TE, Lu J. 2005. Hypothalamic regulation of sleep and circadian rhythms. Nature. 437:1257–63.
  • Severino G, Manchia M, Contu P, Squassina A, Lampus S, Ardau R, Chillotti C, Del Zompo M. 2009. Association study in a Sardinian sample between bipolar disorder and the nuclear receptor REV-ERBalpha gene, a critical component of the circadian clock system. Bipolar Disord. 11:215–20.
  • Simonneaux V, Ribelayga C. 2003. Generation of the melatonin endocrine message in mammals: A review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev. 55:325–95.
  • Souza-Teodoro LH, Dargenio-Garcia L, Petrilli-Lapa CL, Souza Eda S, Fernandes PA, Markus RP, Ferreira ZS. 2016. Adenosine triphosphate inhibits melatonin synthesis in the rat pineal gland. J Pineal Res. 60:242–49.
  • Sumova A, Sladek M, Jac M, Illnerova H. 2002. The circadian rhythm of Per1 gene product in the rat suprachiasmatic nucleus and its modulation by seasonal changes in daylength. Brain Res. 947:260–70.
  • Taher AT, Saliba AN, Kuo KH, Giardina PJ, Cohen AR, Neufeld EJ, Aydinok Y, Kwiatkowski JL, Jeglinski BI, Pietropaolo K, et al. 2017. Safety and pharmacokinetics of the oral iron chelator SP-420 in beta-thalassemia. Am J Hematol. 92:1356–61.
  • Takahashi JS, Hong HK, Ko CH, McDearmon EL. 2008. The genetics of mammalian circadian order and disorder: Implications for physiology and disease. Nat Rev Genet. 9:764–75.
  • Terman M, Terman JS, Quitkin FM, Cooper TB, Lo ES, Gorman JM, Stewart JW, McGrath PJ. 1988. Response of the melatonin cycle to phototherapy for seasonal affective disorder. Short note. J Neural Transm. 72:147–65.
  • Tournier BB, Dardente H, Simonneaux V, Vivien-Roels B, Pevet P, Masson-Pevet M, Vuillez P. 2007. Seasonal variations of clock gene expression in the suprachiasmatic nuclei and pars tuberalis of the European hamster (Cricetus cricetus). Eur J Neurosci. 25:1529–36.
  • Tyrer AE, Levitan RD, Houle S, Wilson AA, Nobrega JN, Meyer JH. 2016a. Increased seasonal variation in serotonin transporter binding in seasonal affective disorder. Neuropsychopharmacology. 2016 Sep;41(10):2447–54.
  • Tyrer AE, Levitan RD, Houle S, Wilson AA, Nobrega JN, Rusjan PM, Meyer JH. 2016b. Serotonin transporter binding is reduced in seasonal affective disorder following light therapy. Acta Psychiatr Scand. 134:410–19.
  • Valvassori SS, Dal-Pont GC, Steckert AV, Varela RB, Lopes-Borges J, Mariot E, Resende WR, Arent CO, Carvalho AF, Quevedo J. 2016. Sodium butyrate has an antimanic effect and protects the brain against oxidative stress in an animal model of mania induced by ouabain. Psych Res. 235:154–59.
  • Walton JC, Weil ZM, Nelson RJ. 2011. Influence of photoperiod on hormones, behavior, and immune function. Front Neuroendocrinol. 32:303–19.
  • Wang J, Patten SB, Williams JV, Currie S, Beck CA, Maxwell CJ, El-Guebaly N. 2005. Help-seeking behaviours of individuals with mood disorders. Can J Psych Revue. 50:652–59.
  • Wang Y, Kuang Z, Yu X, Ruhn KA, Kubo M, Hooper LV. 2017. The intestinal microbiota regulates body composition through NFIL3 and the circadian clock. Science. 357:912–16.
  • Witkovsky P. 2004. Dopamine and retinal function. Doc Ophthalmol Adv Ophthal. 108:17–40.
  • Young JW, Cope ZA, Romoli BSchrurs E, Aniek J, van Enkhuizen J, Sharp RF, Dulcis D. (In press). Mice with reduced DAT levels recreate seasonal-induced switching between states in bipolar disorder. Neuropsychopharmacology. 2018 Feb 27. doi:10.1038/s41386-018-0031-y. [Epub ahead of print]
  • Zhang L, Du J, Yano N, Wang H, Zhao YT, Dubielecka PM, Zhuang S, Chin YE, Qin G, Zhao TC. 2017. Sodium butyrate protects against high fat diet-induced cardiac dysfunction and metabolic disorders in type II diabetic mice. J Cell Biochem. 118:2395–408.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.